美國Cepher公司介紹
Cepher公司成立于1996年，是一個開發(fā)生產(chǎn)用于生命科學研究和傳染性疾病診斷一起的廠家。Cepheid上市代碼CPHD，總部在美國加州桑尼維爾，是一家分子診斷公司，致力于開發(fā)、生產(chǎn)、商品化用于臨床、工業(yè)、防生物武器的基因分析全整合系統(tǒng)。公司的快速復(fù)雜系統(tǒng)可以替代原有的復(fù)雜的實驗室手工操作，自動化檢測生命體和基因疾病。易用的系統(tǒng)整合了一系列復(fù)雜和耗時的步驟，包括樣品制備、DNA擴增及檢測，這樣就可以在公司專有的監(jiān)測盒中分析復(fù)雜的生物樣品。擁有強大的分子生物學能力，公司致力于發(fā)展可以用于需要快速分子檢測的方法，如在臨床中的發(fā)現(xiàn)傳染性疾病和腫瘤，工業(yè)市場中的食品、農(nóng)業(yè)、環(huán)境測試，反生物恐怖中的發(fā)現(xiàn)生物恐怖病源體。
Cepheid (Nasdaq: CPHD), based in Sunnyvale, Calif., is an on-demand molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets. The Company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Cepheid's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the Company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market.
- 上一篇：香港今年冬季流感已致64人死亡 2015/1/29
- 下一篇：香港流感爆發(fā) 2015/1/29
